Mission and strategy

The mission is to create new knowledge and competitive on the world market products of bioengineering and molecular genetic technologies in priority clinical areas (oncology, neurology, cardiology, ophthalmology), the creation of unique pharmaceutical technologies.

The strategic goal is to transform into an international innovative University of Life science (University 4.0) with a 1.5-fold increase in the number of graduates and R&D revenues up to 1 billion rubles by 2030.